PharmacyCodes



Minaprina [Inn-Spanish] en es it fr

Minaprina [Inn-Spanish] Brand names, Minaprina [Inn-Spanish] Analogs

Minaprina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Minaprina [Inn-Spanish] Chemical_Formula

C17H22N4O

Minaprina [Inn-Spanish] RX_link

No information avaliable

Minaprina [Inn-Spanish] fda sheet

Minaprina [Inn-Spanish] msds (material safety sheet)

Minaprina [Inn-Spanish] Synthesis Reference

C.G. Wermuth et al., Agressologie 13, 285 (1972)

Minaprina [Inn-Spanish] Molecular Weight

298.383 g/mol

Minaprina [Inn-Spanish] Melting Point

122 oC

Minaprina [Inn-Spanish] H2O Solubility

2360 mg/L

Minaprina [Inn-Spanish] State

Solid

Minaprina [Inn-Spanish] LogP

1.157

Minaprina [Inn-Spanish] Dosage Forms

No information avaliable

Minaprina [Inn-Spanish] Indication

For the treatment of depression

Minaprina [Inn-Spanish] Pharmacology

Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. Similar to other antidepressant treatments, minaprine attenuates the beta-adrenergic receptor function. Studies have also shown that minaprine improves memory consolidation and that repeated drug administration leads to potentiation of this effect. Moreover, the effects of minaprine on memory consolidation are related to its dopaminergic action.

Minaprina [Inn-Spanish] Absorption

No information avaliable

Minaprina [Inn-Spanish] side effects and Toxicity

No information avaliable

Minaprina [Inn-Spanish] Patient Information

No information avaliable

Minaprina [Inn-Spanish] Organisms Affected

Humans and other mammals